The effect of price control on drug expenses in Finland
Salonen, R.; Idänpään-Heikkilä, J.
Nordisk Medicin 90(3): 90-91
1975
ISSN/ISBN: 0029-1420 PMID: 1153262 Document Number: 91420
Document emailed within 1 workday
Related Documents
Jääskeläinen, M. 1979: Guidelines for health services in the 1980's in Finland. The increase in personnel and expenses will be slowed down. Should young people be educated for unemployment? Nordisk Medicin 94(6-7): 186-1871999: Treatment of drug dependence in Finland. November 1-3, 1999, Espoo, Finland Duodecim; laaketieteellinen aikakauskirja 115(22): 2510-2522
Sakakura, E. 2006: Relationship between medical expenses for the aged residing in farming villages and a social support network--documentation using details of medial expenses Hokkaido Journal of Medical Science 81(1): 53-65
Yang, H. 2010: The effect of evidence-based evaluation and economic evaluation for price control of medical disposable materials Zhongguo Yi Liao Qi Xie Za Zhi 34(3): 221-223
Jaklevic, M.Chris. 2003: The price of drug coverage Modern Healthcare 33(26): 18
Halse, M. 1975: Price control on drugs in Norway Nordisk Medicin 90(3): 92-93
Mossinghoff, G.J. 1986: Drug price increase explained American Pharmacy 26(4): 5-6
Wagner, L. 1992: Coalition seeks changes in drug price law Modern Healthcare 22(30): 16
Goriachev, D.V.; Erdes, S.F. 2004: Markov model of decision making for basic therapy of rheumatoid arthritis: oder of monotherapy and expenses for drug therapy Terapevticheskii Arkhiv 76(5): 35-39
Mäkinen-Kiljunen, S.; Backman, A. 1994: Control of allergen preparations in Finland. Ten years of experience Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 1994(87): 17-25; Discussion 114-7
Hopp, P.; Wahlström, H.; Hirn, J. 1999: A common Salmonella control programme in Finland, Norway and Sweden Acta Veterinaria Scandinavica. Supplementum 91: 45-49
Rimpelä, M.; Rimpelä, A.; Kosunen, E. 1996: From control policy to comprehensive family planning: success stories from Finland Promotion and Education 3(3): 28-32; 48
Schleifer, R.; Pol, L. 2017: International Guidelines on Human Rights and Drug Control: A Tool for Securing Women's Rights in Drug Control Policy Health and human rights 19(1): 253-261
2004: Strategic price setting: ensuring your financial viability through price modeling Healthcare financial management: journal of the Healthcare Financial Management Association 58(7): 1-7
Elmes, J.; Nhongo, K.; Ward, H.; Hallett, T.; Nyamukapa, C.; White, P.J.; Gregson, S. 2014: The price of sex: condom use and the determinants of the price of sex among female sex workers in eastern Zimbabwe Journal of Infectious Diseases 210(Suppl 2): S569-S578
Kirkner, R.M. 2017: To Dent Soaring Drug Costs, States Turn to 'Price-Gouging' Laws Managed Care 26(9): 8-9
Meiners, C.; Sagaon-Teyssier, L.; Hasenclever, L.; Moatti, J.-P. 2011: Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth? Plos one 6(8): E23478
Burda, D. 1993: Drugmakers' price plan ruled to be price-fixing by agency Modern Healthcare 23(41): 8
Korhonen, K.; Raitanen, J.; Isola, J.; Haapasalo, H.; Salminen, T.; Auvinen, A. 2010: Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland Cancer Causes and Control: Ccc 21(12): 2149-2156
Hetherington, R.W.; Epstein, M.; Gerstel, B. 1969: The control of quality and price of medical care through provision of a preselected panel of private practitioners Medical Care 7(1): 21-29